Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

N/A

File Name: neogen_com---09067.asp
PanaKare鈩? Plus
Tablets
Pancreatic Enzyme Concentrate Plus Fat
Soluble Vitamins



Indications
For use as a digestive aid in replacement therapy where
digestion of protein, carbohydrates and fat is inade-
quate due to exocrine pancreatic insuf铿乧iency.

Directions for Use
PanaKare Plus is administered before each meal and
is estimated according to the severity of the condition
and weight of the animal.
Average dose/meal:
Dogs: 2鈥?3 tablets
Cats: 陆鈥?1 tablet

Caution
Discontinue use in animals with symptoms of sensitivity.
Federal law restricts this drug to use by or on the order
Description of a licensed veterinarian. For animal use only.
PanaKare Plus is a pancreatic enzyme concentrate of
Storage
porcine origin forti铿乪d with the fat soluble vitamins A,
D and E. Store tightly closed container in a dry place at a tem-
perature not exceeding 25掳C (77掳F).
Each tablet contains:
Lipase ........................................................9,000 USP units
Vitamin Therapy
Protease ..................................................57,000 USP units
Serum concentrations of the fat soluble vitamins A, E
Amylase ..................................................64,000 USP units
and D3 are often sub-normal in pancreatic insuf铿乧ien-
Vitamin A ........................................................... 1,000 IUs
cy in dogs and cats and do not increase in response to
Vitamin D3 ............................................................. 100 IUs
enzyme treatment. While ideal dosage levels have not
Vitamin E ................................................................. 10 IUs
been of铿乧ially established, oral supplementation of fat
soluble vitamins is widely accepted and recommend by
leading researchers and practitioners.

Presentation
09067 PanaKare Plus Tablets (100 ct) 12 per case Rx
09068 PanaKare Plus Tablets (500 ct) 12 per case Rx




漏Neogen Corporation 鈥? 944 Nandino Blvd. 鈥? Lexington, KY 40511 USA 鈥? 800/525-2022 鈥? 859/254-1221 鈥? Fax: 877/228-7229 鈥? inform@neogen.com 鈥? www.neogen.com
AN060-1105
PanaKare is a trademark of Neogen Corporation.

Search    ENTER KEYWORD
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
my_okidata_com---58357301.asp N/A
my_okidata_com---58357401_efsp.asp N/A
my_okidata_com---58357601_efsp.asp N/A
my_okidata_com---58358601.asp 84179-66-8
my_okidata_com---58367401_e.asp 1309-38-2 7631-86-9
my_okidata_com---58371301_efsp.asp 1333-86-4
my_okidata_com---58375301.asp N/A
my_okidata_com---58375401.asp N/A
my_okidata_com---58375601_efsp.asp N/A
my_okidata_com---58381801_efsp.asp N/A
my_okidata_com---58381901_efsp.asp N/A
my_okidata_com---58382001_efsp.asp N/A
my_okidata_com---msds_58065301_ribbon_black_for_ml395_395c.asp N/A
my_okidata_com---msds_58065401_ribbon_color_for_ml395_395c.asp 8012-95-1
my_okidata_com---msds_58065501_ribbon_black_film_for_ml395_395c.asp N/A
naturalindustries_com---108.label.msds.asp N/A
naturalindustries_com---ag.msds.asp N/A
naturalindustries_com---dt9.label.msds.asp N/A
naturalindustries_com---seed.label.msds.asp N/A
neogen_com---08820.asp N/A
neogen_com---08838.asp N/A
neogen_com---08839.asp N/A
neogen_com---08866.asp N/A
neogen_com---08874.asp N/A
neogen_com---08879.asp N/A
neogen_com---08880.asp N/A
neogen_com---08883.asp N/A
neogen_com---08884.asp N/A
neogen_com---08888.asp N/A
neogen_com---09055.asp N/A
neogen_com---09062.asp N/A
neogen_com---09063.asp N/A
neogen_com---09064-09066.asp N/A
neogen_com---09067.asp N/A
neogen_com---09068.asp N/A
neogen_com---09070.asp N/A
neogen_com---09071.asp N/A
neogen_com---09072.asp N/A
neogen_com---09073.asp N/A
neogen_com---09074-09076.asp N/A
neogen_com---09080.asp N/A
neogen_com---09081.asp N/A
neogen_com---09085.asp N/A
neogen_com---09090-09093.asp N/A
neogen_com---09094.asp N/A
neogen_com---09095.asp N/A
neogen_com---09100-09115.asp N/A
neogen_com---09116.asp N/A
neogen_com---09117.asp N/A
neogen_com---142674.asp N/A

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com | Ads link:HBCCHEM.INC